Introducing the world’s youngest billionaire, a discreet heir who has quietly built a $5.7 billion fortune with many unaware of his existence.
While most billionaires are aged between 50 and 79, there are a few individuals who achieve this financial milestone even before completing their education.
How unusual is such an accomplishment? As per Forbes, there are a mere 21 billionaires under the age of 30 globally, with all but two having inherited their wealth.
The two young self-made billionaires are Ed Craven from Australia, aged 29, cofounder of the crypto-backed online casino Stake.com, and Alexandr Wang from the United States, aged 28, cofounder of AI data firm Scale AI.
Included in the under-30 billionaire list are siblings who have inherited fortunes from Boehringer Ingelheim. The youngest among these siblings has recently been recognized as the youngest billionaire globally.
Johannes von Baumbach has been identified as the youngest billionaire in the world at just 20 years old, owing to his family’s stake in Boehringer Ingelheim.
Johannes is one of four von Baumbach siblings, aged 24, 26, and 27, each with an estimated net worth of around $5.7 billion.
The family is known for their privacy, and it is not clear whether Johannes or his siblings have any positions within the company, which has been under the leadership of their uncle, Hubertus von Baumbach, since 2015. Beyond the business realm, Johannes is an active participant in skiing events in Austria.
Boehringer Ingelheim stands as the world’s largest privately-owned pharmaceutical company, a family-managed enterprise that has accumulated significant wealth across generations.
Established in 1885 by Albert Boehringer and located in Ingelheim am Rhein, Germany, the health company has progressed over approximately 140 years to become a leader in both human and animal health.
The company provides a wide array of medicines and therapies, including treatments for respiratory diseases like COPD and asthma, innovative methods for managing type 2 diabetes, and advanced anticoagulation drugs to reduce the risk of stroke and blood clots.
Boehringer Ingelheim’s website states: “Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.”
Its Animal Health division is another global leader in veterinary medicine, committed to developing and delivering products that safeguard and improve animal well-being.
This division produces vaccines, parasiticides, pharmaceuticals, and other innovative therapies for both companion animals and livestock.
In case you’re curious, Elon Musk remains the richest person in the world, with his net worth currently at $477.4 billion, primarily derived from his stakes in Tesla and SpaceX.